Case Type: Mergers & Acquisitions

Kimball International, Inc. (NASDAQ: KBAL), relating to its proposed sale to HNI Corp. Under the terms of the agreement KBAL shareholders are expected to receive $9.00 in cash per share they own.

Diversey Holdings, Ltd. (NASDAQ: DSEY), relating to its proposed sale to Solenis. Under the terms of the agreement DSEY shareholders are expected to receive $8.40 in cash per share they own.

Radius Global Infrastructure, Inc. (NASDAQ: RADI), relating to its proposed sale to EQT Active Core Infrastructure and Public Sector Pension Investment Board. Under the terms of the agreement, RADI shareholders are expected to receive $15.00 in cash per share they own.

TCR² Therapeutics Inc. (NASDAQ: TCRR), relating to its proposed sale to Adaptimmune Therapeutics plc. Under the terms of the agreement, TCRR shareholders are expected to receive 1.5117 shares of Adaptimmune per share they own.

Adaptimmune Therapeutics plc (NASDAQ: ADAP), relating to its proposed merger with TCR² Therapeutics Inc. Under the terms of the agreement, ADAP shareholders are expected to own approximately 75% of the combined company.

Ranger Oil Corp. (NASDAQ: ROCC), relating to its proposed sale to Baytex Energy Corp. Under the terms of the agreement, ROCC shareholders are expected to receive 7.49 shares of Baytex and $13.31 in cash per share they own.

Adamis Pharmaceuticals Corp. (NASDAQ: ADMP), relating to its proposed merger with DMK Pharmaceuticals Corp.

Jounce Therapeutics, Inc. (NASDAQ: JNCE), relating to its proposed merger with Redx Pharma.

Broadmark Realty Capital Inc. (NYSE: BRMK), relating to its proposed merger with Ready Capital Corp. Under the terms of the agreement, BRMK shareholders are expected to receive 0.47233 shares of Ready Capital stock per share they own.

Focus Financial Partners Inc. (NASDAQ: FOCS), relating to its proposed sale to affiliates of Clayton Dubilier & Rice LLC. Under the terms of the agreement, FOCS shareholders are expected to receive $53.00 in cash per share they own.